Deferred Tax Assets, Valuation Allowance of TITAN PHARMACEUTICALS INC from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
TITAN PHARMACEUTICALS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
  • TITAN PHARMACEUTICALS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $60,480,000, a 7% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

TITAN PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $60,480,000 -$4,547,000 -7% 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q4 2023 $65,027,000 -$5,311,000 -7.6% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q4 2022 $70,338,000 -$7,545,000 -9.7% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q4 2021 $77,883,000 -$2,439,000 -3% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q4 2020 $80,322,000 -$490,000 -0.61% 31 Dec 2020 10-K 25 Mar 2022 2021 FY
Q4 2019 $80,812,000 +$742,000 +0.93% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 $80,070,000 +$197,000 +0.25% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q4 2017 $79,873,000 -$24,353,000 -23% 31 Dec 2017 10-K/A 02 Apr 2019 2018 FY
Q4 2016 $104,226,000 -$4,440,000 -4.1% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $108,666,000 +$2,740,000 +2.6% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q4 2014 $105,926,000 +$455,000 +0.43% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q4 2013 $105,471,000 +$1,655,000 +1.6% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q4 2012 $103,816,000 +$3,121,000 +3.1% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q4 2011 $100,695,000 31 Dec 2011 10-K 18 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.